Fiscal year 2024 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses ITOS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ITOS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Michel Detheux | $628,684 | $0 | $0 | $4,965,264 | $421,014 | $0 | $70,695 | $6,085,657 |
| Chief Executive Officer | ||||||||
| David Feltquate | 214,271 | 0 | 391,040 | 4,189,500 | 250,320 | 0 | 9,874 | 5,055,005 |
| Chief Medical Officer | ||||||||
| Matthew Call | 491,734 | 0 | 0 | 1,892,250 | 215,777 | 0 | 17,970 | 2,617,730 |
| Chief Operating Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Michel Detheux | $6,085,657 | — | — | — |
| David Feltquate | 5,055,005 | — | — | — |
| Matthew Call | 2,617,730 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Michel Detheux | OPTION | 2024-03-07 | — | — | 590,400 | — | $4,965,264 |
| Matthew Call | OPTION | 2024-03-07 | — | — | 225,000 | — | 1,892,250 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Michel Detheux | $0 | $0 | $4,965,264 | 0.0% |
| Matthew Call | 0 | 0 | 1,892,250 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Michel Detheux | RSU | 30,000 | — | $230,400 |
| Michel Detheux | RSU | 3,125 | — | 24,000 |
| Matthew Call | Option | 26,562 | 36.21 | — |
| Matthew Call | Option | 73,125 | 16.66 | — |
| David Feltquate | RSU | 47,000 | — | 360,960 |
| Michel Detheux | Option | 9,000 | 41.58 | — |
| Michel Detheux | Option | 590,400 | 11.58 | — |
| Matthew Call | Option | 9,000 | 23.19 | — |
| Michel Detheux | Option | 194,626 | 16.66 | — |
| Michel Detheux | Option | 110,156 | 36.21 | — |
| Matthew Call | RSU | 44,000 | — | 337,920 |
| Matthew Call | Option | 225,000 | 11.58 | — |
| Matthew Call | Option | 4,500 | 41.58 | — |
| David Feltquate | Option | 350,000 | 17.46 | — |
We use base salaries to recognize the experience, skills, knowledge and responsibilities required of all our employees, including our named executive officers. Base salaries are reviewed annually, typically in connection with our annual performance review process, approved by our Board, and adjusted from time to time to realign salaries with market levels after taking into account individual resp
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Radford |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Jill DeSimoneIndependent · Audit · Compensation and Leadership Development · Newly elected | $28,826 | $0 | $657,444 | $0 | $0 | $686,270 |
| David L. HallalIndependent · Board Chair · Nominating and Corporate Governance (Chair) | 161,860 | 0 | 280,962 | 0 | 0 | 442,822 |
| Ann D. RhoadsIndependent · Audit (Chair) · Compensation and Leadership Development · Nominating and Corporate Governance | 64,604 | 0 | 280,962 | 0 | 0 | 345,566 |
| Robert IannoneIndependent · Compensation and Leadership Development · Science and Technology (Chair) | 60,302 | 0 | 280,962 | 0 | 0 | 341,264 |
| Tony HoIndependent · Nominating and Corporate Governance · Science and Technology | 51,802 | 0 | 280,962 | 0 | 0 | 332,764 |
| Tim Van HauwermeirenIndependent · Compensation and Leadership Development (Chair) | 50,604 | 0 | 280,962 | 0 | 0 | 331,566 |
| David K. LeeIndependent · Audit | 39,110 | 0 | 280,962 | 0 | 0 | 320,072 |
| Aaron DavisIndependent · Departed during FY | — | 0 | 280,962 | 0 | 0 | 280,962 |
| Michel DetheuxEmployee director · Science and Technology | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $280,962 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $457,108 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $457,108 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | iTeos Therapeutics | 2024 | Michel Detheux | $628,684 | $0 | $4,965,264 | $421,014 | $6,085,657 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Michel Detheux | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Summary Compensation Table”. As printed: 6,085,657. Filing ↗machine: r2 · c27 · span 499272–499281 |
| 2 | Section 01, David Feltquate | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Summary Compensation Table”. As printed: 5,055,005. Filing ↗machine: r6 · c27 · span 536184–536193 |
| 3 | Section 01, Matthew Call | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Summary Compensation Table”. As printed: 2,617,730. Filing ↗machine: r4 · c27 · span 517603–517612 |
| 4 | Section 03, Michel Detheux OPTION | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t10 · r2 · c13 · span 456007–456016 |
| 5 | Section 03, Matthew Call OPTION | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t10 · r3 · c13 · span 463687–463696 |
| 6 | Section 08, Jill DeSimone | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 686,270. Filing ↗machine: t8 · r3 · c15 · span 370460–370467 |
| 7 | Section 08, David L. Hallal | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 442,822. Filing ↗machine: t8 · r4 · c15 · span 375972–375979 |
| 8 | Section 08, Ann D. Rhoads | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 345,566. Filing ↗machine: t8 · r9 · c15 · span 403518–403525 |
| 9 | Section 08, Robert Iannone | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 341,264. Filing ↗machine: t8 · r7 · c15 · span 392501–392508 |
| 10 | Section 08, Tony Ho | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 332,764. Filing ↗machine: t8 · r6 · c15 · span 386991–386998 |
| 11 | Section 08, Tim Van Hauwermeiren | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 331,566. Filing ↗machine: t8 · r5 · c15 · span 381488–381495 |
| 12 | Section 08, David K. Lee | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 320,072. Filing ↗machine: t8 · r8 · c15 · span 398009–398016 |
| 13 | Section 08, Aaron Davis | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 280,962. Filing ↗machine: t8 · r2 · c7 · span 362404–362411 |
| 14 | Section 08, Michel Detheux | DEF 14A | 2025-04-24 | 0000950170-25-057666 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 15 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 16 | Section 09b board cost (computed) | Computed | — | computed | Cash 457,108 + equity 0 + all other 0 = 457,108, summed across the director compensation table rows.machine: formula: Σ = 457,108 |
| 17 | iTeos Therapeutics (subject), Section 10b CEO total | DEF 14A | 2025-04-24 | 0000950170-25-057666 | CEO total compensation as printed in iTeos Therapeutics's own proxy. As printed: 6,085,657. Filing ↗machine: r2 · c27 · span 499272–499281 |